Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China · Delayed Price · Currency is CNY 27.40
+0.56 (2.09%)
At close: Jun 9, 2026
SHE:301246 Market Cap
SHE:301246 has a market cap or net worth of 10.87 billion as of June 9, 2026. Its market cap has increased by 105.24% in one year.
Market Cap
10.87B
Enterprise Value
9.88B
Revenue
2.21B
Ranking
n/a
PE Ratio
42.74
Stock Price
27.40
Market Cap Chart
Since March 20, 2023, SHE:301246's market cap has decreased from 16.78B to 10.87B, a decrease of -35.21%. That is a compound annual growth rate of -12.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 10.65B | 7.36% |
| Dec 31, 2025 | 9.92B | 84.22% |
| Dec 31, 2024 | 5.39B | -48.18% |
| Dec 29, 2023 | 10.39B | -38.07% |
| Mar 20, 2023 | 16.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guobang Pharma | 12.44B |
| Henan Lingrui Pharmaceutical | 12.25B |
| Shanghai Shyndec Pharmaceutical | 12.02B |
| Beijing Aosaikang Pharmaceutical | 11.99B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 11.98B |
| Zhejiang Medicine | 11.54B |
| Shenzhen Chipscreen Biosciences | 11.32B |
| Zhejiang Hisun Pharmaceutical | 11.29B |